Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease H1 pseudogene 1 (RNASEH1P1) is a non-functional segment of genomic DNA similar to the functional RNASEH1 gene. It does not encode a functional protein and is considered a pseudogene. The presence of RNASEH1P1 in the human genome reflects sequence similarity and evolutionary origin shared with the RNASEH1 gene, which encodes a ribonuclease involved in processing RNA-DNA hybrids during DNA replication and repair[2][4][6]. RNASEH1P1 itself is not known to participate in any biological process, disease, or therapeutic function. Important clarification: RNASEH1 (Ribonuclease H1), its protein product, and the associated lncRNA RNASEH1-AS1 are sometimes discussed in oncology and molecular biology contexts as active molecules, but RNASEH1P1 is specifically a pseudogene and should not be confused with the active ribonuclease. Any references to therapeutics, disease roles, or biological function for "RNASEH1" or "RNH1" refer to the protein-coding gene, not this pseudogene[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease H1 pseudogene 1 (RNASEH1P1).